Moors & Cabot’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-200
Closed -$3K – 814
2022
Q1
$3K Buy
+200
New +$13.7K ﹤0.01% 872

Other funds holding ACLS

Moors & Cabot's ACLS Position: Q3 2026 in Review

Moors & Cabot reduced its Axcelis (ACLS) stake by 3% in Q3 2026, selling an estimated $17.3K and leaving 4,365 shares worth $573K. The position accounts for 0.02% of the portfolio, ranked #524.

Moors & Cabot first reported a position in ACLS in Q1 2021 and has held it in 23 quarters since. The position peaked at $1.88M in Q2 2023. 202 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • Moors & Cabot held 4,365 shares of Axcelis worth $573K as of Q3 2026.
  • Moors & Cabot sold 135 Axcelis shares in Q3 2026, an estimated $17.3K.
  • Axcelis made up 0.02% of Moors & Cabot's portfolio in Q3 2026, its #524 holding.
  • Moors & Cabot first reported a position in Axcelis in Q1 2021 and has held it in 23 quarters since.
  • Moors & Cabot's Axcelis position peaked at $1.88M in Q2 2023.
  • 202 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.